Category: Cardiac Rhythm Management
Abiomed Impella Granted Emergency Use Authorization to Treat COVID-19 Cardiac Symptoms
The FDA has granted Emergency Use Authorization to Abiomed for their left-sided Impella heart pumps. These pumps are used to support patients during heart failure and provide left ventricular unloadin... Read More
Boston Scientific Granted FDA Approval for Stroke Prevention Device
According to iData’s latest Interventional Cardiology market report, Boston Scientific is the leading competitor in this market. Now, they have produced another innovative interventional cardiol... Read More
Medtronic receives CE mark for Micra AV Pacemaker
Medtronic has received a CE mark for its Micra AV Pacemaker, the world’s smallest pacemaker with atrioventricular (AV) synchrony. This device is used to treat AV block, a condition marked by impaire... Read More
Boston Scientific Given FDA 510(k) Clearance for Insertable Cardiac Monitor System
Boston Scientific has been granted FDA 510(k) clearance for their LUX-Dx insertable cardiac monitor system. This long-term diagnostic device is used to detect arrhythmias from conditions such as atria... Read More
Bardy Dx Patch Monitors Coronavirus Patients Prescribed HCQ
Bardy Diagnostics‘ Carnation Ambulatory Monitor (CAM™) Patch is being used by Seattle health care workers to monitor heart beat and measure QT segments in coronavirus patients prescribed HCQ e... Read More
AI Predicts Heart Failure Hospitalization up to 10 Days in Advance
AI Predicts Heart Failure Hospitalization up to 10 Days in Advance PhysIQ and U.S. Veteran’s Affairs have published successful clinical trial results showing how artificial intelligence (AI) can be ... Read More
Baylis Medical Introduces 2F Electrophysiology Catheter
Register to receive a free Cardiac Rhythm Management Market Analysis, Size and Trends Report synopsis and brochure. Baylis Medical, a developer of innovative cardiological devices and therapies, recen... Read More
AtriCure Enters Into Definitive Agreement to Acquire SentreHEART for Up to $300 Million
Register to receive a free U.S. Market Report Suite for Cardiac Rhythm Management Devices – MedSuite report synopsis and brochure AtriCure, Inc., a leading player in treatments for atrial fibrilla... Read More
BIOTRONIK Announces Launch of Next Generation Injectable Cardiac Monitor
Register to receive a free U.S. Market Report Suite for Cardiac Rhythm Management Devices – MedSuite report synopsis and brochure Biotronik is releasing a new version of its popular Biomonitor inj... Read More- 2 of 4
- « Previous
- 1
- 2
- 3
- 4
- Next »
